PUBLICATION

p53 genes function to restrain mobile elements

Authors
Wylie, A., Jones, A.E., D'Brot, A., Lu, W.J., Kurtz, P., Moran, J.V., Rakheja, D., Chen, K.S., Hammer, R.E., Comerford, S.A., Amatruda, J.F., Abrams, J.M.
ID
ZDB-PUB-151225-3
Date
2016
Source
Genes & Development   30(1): 64-77 (Journal)
Registered Authors
Amatruda, James F.
Keywords
Drosophila, human cancers, mouse cancer models, p53, piRNAs, retrotransposons, zebrafish
MeSH Terms
  • Animals
  • Drosophila/genetics
  • Female
  • Genes, p53/genetics*
  • Genetic Variation
  • Humans
  • Male
  • Mice
  • Mutation/genetics
  • Neoplasms/genetics
  • Retroelements/genetics
  • Retroelements/physiology*
  • Tumor Suppressor Protein p53/genetics*
  • Tumor Suppressor Protein p53/metabolism*
  • Zebrafish/genetics
PubMed
26701264 Full text @ Genes & Dev.
Abstract
Throughout the animal kingdom, p53 genes govern stress response networks by specifying adaptive transcriptional responses. The human member of this gene family is mutated in most cancers, but precisely how p53 functions to mediate tumor suppression is not well understood. Using Drosophila and zebrafish models, we show that p53 restricts retrotransposon activity and genetically interacts with components of the piRNA (piwi-interacting RNA) pathway. Furthermore, transposon eruptions occurring in the p53(-) germline were incited by meiotic recombination, and transcripts produced from these mobile elements accumulated in the germ plasm. In gene complementation studies, normal human p53 alleles suppressed transposons, but mutant p53 alleles from cancer patients could not. Consistent with these observations, we also found patterns of unrestrained retrotransposons in p53-driven mouse and human cancers. Furthermore, p53 status correlated with repressive chromatin marks in the 5' sequence of a synthetic LINE-1 element. Together, these observations indicate that ancestral functions of p53 operate through conserved mechanisms to contain retrotransposons. Since human p53 mutants are disabled for this activity, our findings raise the possibility that p53 mitigates oncogenic disease in part by restricting transposon mobility.
Genes / Markers
Figures
Expression
Phenotype
Mutations / Transgenics
Human Disease / Model
Sequence Targeting Reagents
Fish
Antibodies
Orthology
Engineered Foreign Genes
Mapping